{"id":2831,"date":"2024-03-18T11:13:14","date_gmt":"2024-03-18T15:13:14","guid":{"rendered":"https:\/\/www.raremed.com\/?p=2831"},"modified":"2024-03-21T15:57:38","modified_gmt":"2024-03-21T19:57:38","slug":"raremed-solutions-voted-1-in-patient-satisfaction-in-the-us","status":"publish","type":"post","link":"https:\/\/www.raremed.com\/insights\/raremed-solutions-voted-1-in-patient-satisfaction-in-the-us\/","title":{"rendered":"RareMed Solutions voted #1 in Patient Satisfaction in the US"},"content":{"rendered":"

RareMed Solutions is proud to announce that it has again set the benchmark for patient satisfaction for the entire nation by earning the #1 spot in MMIT\u2019s nationwide Patient Satisfaction Survey. Team RareMed topped the chart by proudly delivering a 98\u2013point Net Promoter Score (NPS), the company\u2019s highest-ever, on the fourth quarter 2023 independent assessment.<\/span>\u00a0<\/span><\/p>\n

RareMed is proud to lead the patient support industry as a direct result of its unrelenting focus on elevating patient care. In the survey, based entirely on anonymous patient feedback, RareMed increased its score over last quarter and once again topped the list. As patient advocates, we are excited to continue to be a pioneer in maximizing the patient experience on behalf of all of those we serve.\u00a0<\/span>\u00a0<\/span><\/p>\n

\"\"
\n<\/span><\/p>\n

\u201cNothing should stand in the way of patient care,\u201d stated RareMed Chairman & CEO Dr. Gordon Vanscoy. \u201cThe hardships patients with rare and complex conditions face every day should be met with care, empathy, and a relentless drive to break through every roadblock they face. At RareMed, our pursuit of elevating the patient experience is uncompromising, and it shows in the satisfaction of our patients, as well as that of our partners and team.\u201d<\/span>\u00a0<\/span><\/p>\n

MMIT conducts their Patient Satisfaction Survey each quarter to analyze and recognize the performance of various specialty pharmacy service providers. The resultant data is compiled and presented to provide benchmarking data to the industry and to patients. <\/span>\u00a0<\/span><\/p>\n

Other RareMed highlights include:\u00a0\u00a0<\/span>\u00a0<\/span>\u00a0<\/span>\u00a0<\/span><\/p>\n